Bioatla, Inc. (BCAB)
NASDAQ:BCAB
Want to see BCAB full AI Analyst Report?
Total Valuation
BioAtla has a market cap or net worth of $7.46M. The enterprise value is $4.48M.
Market Cap$7.46M
Enterprise Value$4.48M
Share Statistics
BioAtla has 1,656,926 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,656,926
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BioAtla’s return on equity (ROE) is 1.65 and return on invested capital (ROIC) is 889.53%.
Return on Equity (ROE)1.65
Return on Assets (ROA)-4.31
Return on Invested Capital (ROIC)889.53%
Return on Capital Employed (ROCE)7.33
Revenue Per Employee32.79K
Profits Per Employee-977.16K
Employee Count61
Asset Turnover0.14
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of BioAtla is ―. BioAtla’s PEG ratio is 0.02.
PE Ratio―
PS Ratio16.70
PB Ratio-0.92
Price to Fair Value-0.92
Price to FCF-0.69
Price to Operating Cash Flow-0.11
PEG Ratio0.02
Income Statement
In the last 12 months, BioAtla had revenue of 2.00M and earned -59.61M in profits. Earnings per share was -50.50.
Revenue2.00M
Gross Profit2.00M
Operating Income-59.30M
Pretax Income-59.61M
Net Income-59.61M
EBITDA-58.93M
Earnings Per Share (EPS)-50.50
Cash Flow
In the last 12 months, operating cash flow was -48.28M and capital expenditures 14.20M, giving a free cash flow of -34.08M billion.
Operating Cash Flow-48.28M
Free Cash Flow-34.08M
Free Cash Flow per Share-20.57
Dividends & Yields
BioAtla pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.20
52-Week Price Change-72.91%
50-Day Moving Average7.87
200-Day Moving Average23.70
Relative Strength Index (RSI)33.48
Average Volume (3m)38.95K
Important Dates
BioAtla upcoming earnings date is May 13, 2026, Before Open (Confirmed).
Last Earnings DateMar 31, 2026
Next Earnings DateMay 13, 2026
Ex-Dividend Date―
Financial Position
BioAtla as a current ratio of 0.37, with Debt / Equity ratio of -17.13%
Current Ratio0.37
Quick Ratio0.37
Debt to Market Cap0.19
Net Debt to EBITDA0.02
Interest Coverage Ratio0.00
Taxes
In the past 12 months, BioAtla has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
BioAtla EV to EBITDA ratio is -0.55, with an EV/FCF ratio of -0.67.
EV to Sales16.24
EV to EBITDA-0.55
EV to Free Cash Flow-0.67
EV to Operating Cash Flow-0.67
Balance Sheet
BioAtla has $7.12M in cash and marketable securities with $6.20M in debt, giving a net cash position of $918.00K billion.
Cash & Marketable Securities$7.12M
Total Debt$6.20M
Net Cash$918.00K
Net Cash Per Share$0.55
Tangible Book Value Per Share-$30.76
Margins
Gross margin is 100.00%, with operating margin of -2965.25%, and net profit margin of -2980.35%.
Gross Margin100.00%
Operating Margin-2965.25%
Pretax Margin-2980.35%
Net Profit Margin-2980.35%
EBITDA Margin-2946.60%
EBIT Margin-2965.25%
Analyst Forecast
The average price target for BioAtla is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-100.00%
EPS Growth Forecast32.37%